Report Description

Forecast Period


Market Size (2024)

USD 1.06 Billion

Market Size (2030)

USD 1.68 Billion

CAGR (2025-2030)


Fastest Growing Segment

Online Pharmacies 

Largest Market

North India


Market Overview

India Insulin Delivery Devices Market was valued at USD1.06 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.90 % through 2030.  Insulin delivery devices constitute essential medical tools and systems designed to administer insulin, a hormone critical for regulating blood sugar levels in individuals with diabetes. These devices facilitate the controlled and precise administration of insulin to maintain blood sugar within target ranges. Among these devices are insulin pens, resembling pens in shape and size, which offer easy and accurate dose settings through pre-filled or replaceable insulin cartridges. Insulin pumps, small electronic devices, provide a continuous insulin supply via a catheter inserted under the skin, allowing for precise control with adjustable basal rates and bolus doses. Additionally, microneedle patches, utilizing tiny needles for painless insulin delivery through the skin, offer a less invasive alternative to injections.

The preference for insulin delivery devices such as pens and pumps over traditional syringes and vials is driven by factors like ease of use, convenience, and improved quality of life for patients. Continuous innovation in device technology, including smart pumps and connected devices, further boosts their adoption rates by enhancing diabetes management. Increasing awareness about diabetes, its complications, and the significance of proper management fuels the demand for insulin delivery devices. Healthcare providers and organizations play a vital role in this process through patient education programs, helping individuals gain a better understanding of diabetes management, including the utilization of insulin delivery devices.

Key Market Drivers

Technological Advancements

Smart insulin pens are equipped with Bluetooth connectivity and smartphone apps, enabling them to record insulin doses, share data with healthcare providers or caregivers, and provide dose reminders. This technology facilitates patient monitoring of insulin usage and adherence to treatment plans. Insulin pumps have evolved with features like closed-loop systems (artificial pancreas) that automatically adjust insulin delivery based on continuous glucose monitoring (CGM) data, maintaining stable blood sugar levels and reducing the risk of hypoglycemia and hyperglycemia. Integration with CGM systems allows for more precise insulin delivery based on real-time glucose data, enhancing remote monitoring and communication with healthcare providers.

Advancements in needle technology have led to thinner and shorter needles, improving patient comfort during injections. Some devices utilize microneedles or spring-loaded mechanisms for a less painful experience. Customizable insulin delivery profiles based on factors like physical activity and meals personalize diabetes management. AI algorithms analyze CGM data to predict blood sugar fluctuations, suggest insulin dosage adjustments, and alert users to potential issues, enhancing diabetes control. Closed-loop insulin delivery systems automatically adjust insulin delivery in response to glucose levels, minimizing manual intervention. Patch insulin delivery devices offer discreet and continuous insulin delivery, ideal for wear on the skin.

Telemedicine platforms and remote monitoring technologies allow healthcare providers to remotely monitor patients' glucose levels and insulin delivery, particularly important during pandemics like COVID-19. Modern insulin delivery devices feature user-friendly interfaces with touchscreen displays and intuitive menus, facilitating ease of use for patients. Real-time data sharing with caregivers or healthcare providers and alerts for extreme blood sugar fluctuations enhance safety and care coordination. Improved battery technology extends device usage times and reduces maintenance requirements, fostering the development of the India Insulin Delivery Devices Market.

Shifting Patient Preference for Insulin Delivery Devices

Patients often favor insulin delivery devices that prioritize user-friendliness and simplicity. Devices like insulin pens and pumps are specifically designed for ease of use, appealing to patients who may feel hesitant about self-administering insulin. Pain reduction during injections is a key consideration, with insulin delivery devices, particularly pen needles, engineered to minimize discomfort. This feature enhances treatment adherence. Insulin pens and pumps offer added convenience, being discreet and portable, enabling patients to administer insulin doses in various settings, fostering flexibility in their daily routines. The precision of dosing provided by these devices is valued by patients for effective diabetes management. Additionally, the discreet nature of insulin pens and pumps helps mitigate potential social stigma associated with diabetes, promoting a sense of normalcy.

Insulin pumps offer enhanced dose flexibility, empowering patients to adjust basal rates and bolus doses according to their individual needs. Personalization features in some devices allow patients to tailor their treatment to suit their lifestyle. Modern insulin delivery devices, particularly those with Bluetooth connectivity, enable patients to monitor insulin usage and blood sugar levels via smartphone apps, promoting engagement in their care. Devices that improve overall quality of life by minimizing the frequency of injections are highly favored. The freedom and flexibility offered by insulin pumps and similar devices positively impact patient well-being. Increasingly, patients seek devices that facilitate remote monitoring and data sharing with healthcare providers or caregivers, aligning with the trend toward telemedicine and remote healthcare.

Patients value having a choice in their treatment decisions and prefer insulin delivery devices that cater to their preferences and lifestyle. Positive feedback and recommendations from other patients or healthcare professionals can significantly influence patient preference for specific insulin delivery devices. These factors are expected to drive demand in the India Insulin Delivery Devices Market.

Increasing Healthcare Awareness

As healthcare awareness expands, more individuals gain knowledge about diabetes, its risk factors, and the significance of effective management. This education often encompasses various insulin delivery methods, fostering a better understanding of devices like insulin pens and pumps. Healthcare awareness initiatives prompt people to undergo regular health check-ups, including diabetes screenings. Early diagnosis often leads to the initiation of insulin therapy, consequently increasing the demand for insulin delivery devices.

Healthcare awareness campaigns also inform individuals about available treatment options for diabetes. Informed patients can make more educated decisions regarding their treatment methods. Understanding the complications associated with diabetes, such as cardiovascular disease and neuropathy, motivates individuals to prioritize their diabetes management. Insulin delivery devices play a crucial role in achieving better glycemic control, thus reducing the risk of complications. Well-informed patients are more likely to adhere to their treatment plans, and insulin delivery devices can simplify this process, enhancing patient compliance and improving health outcomes. The dissemination of information about technological advancements in healthcare drives patients to seek the latest and most advanced insulin delivery devices offering improved ease of use and better diabetes control. Healthcare awareness initiatives also emphasize preventive measures to mitigate the risk of chronic conditions like diabetes. Despite preventive efforts, individuals may have family members or acquaintances with diabetes, leading to increased demand for insulin delivery devices.

Improved healthcare awareness facilitates better access to healthcare services, including diabetes management, resulting in increased demand for insulin delivery devices as patients have more opportunities to discuss treatment options with healthcare providers. Healthcare professionals play a crucial role in educating patients about diabetes and insulin delivery devices, influencing patient preferences. Empowered patients become more proactive in managing their health, driving interest in exploring different insulin delivery options and advocating for their preferences. Community support for individuals with diabetes, fostered by support groups and educational programs, encourages the exchange of information, including experiences with insulin delivery devices, further fueling demand for these devices. This trend is expected to accelerate the demand for insulin delivery devices in the India market.

Download Free Sample Report

Key Market Challenges

Counterfeit Products

Counterfeit insulin delivery devices can compromise patient safety. Patients may unknowingly use substandard or ineffective devices, putting their health at risk. Substandard insulin delivery devices can lead to incorrect dosing, poor glycemic control, and adverse events. The presence of counterfeit products affects the market by undermining the revenue of legitimate manufacturers and distributors. This can lead to financial losses for the industry and reduced incentives for investment in research and development of new and improved devices. The presence of counterfeit insulin delivery devices can damage the reputation of established brands and manufacturers. Patients and healthcare providers may lose trust in the authenticity and quality of these devices. Counterfeit products can create unfair competition in the market. Legitimate manufacturers face challenges in competing with counterfeit products that may be available at lower prices due to reduced quality control and safety standards. Counterfeit products can evade regulatory oversight and quality control measures. This undermines efforts by regulatory authorities to ensure the safety and efficacy of medical devices. The use of counterfeit insulin delivery devices can have severe public health implications, particularly when it results in adverse health outcomes or treatment failures for patients with diabetes.

Cultural Beliefs and Stigmas

In many Indian cultures, traditional remedies and alternative therapies hold deep-rooted significance. Some individuals may prefer traditional treatments over Western medicine, including insulin therapy. This can lead to delayed or inadequate diabetes management. A common cultural stigma is a fear of needles and injections. Many people with diabetes may avoid insulin therapy, especially if it involves syringes or needles. This can deter the adoption of insulin delivery devices. Cultural beliefs and misconceptions about diabetes and insulin can create barriers to proper treatment. Some individuals may associate diabetes with negative connotations or believe that insulin is harmful, leading to resistance in using insulin delivery devices. Stigmatization of individuals with diabetes can lead to secrecy and reluctance to openly discuss the condition. This can prevent patients from seeking the best treatment options, including insulin delivery devices. Cultural dietary practices can affect diabetes management. Patients may struggle to adapt their traditional diets to their treatment plans, potentially affecting the effectiveness of insulin therapy. Cultural factors may contribute to a lack of awareness about diabetes and its management. Patients may not be well-informed about the available insulin delivery options. Family dynamics and cultural norms can influence healthcare decisions. In some cases, family members may be resistant to accepting insulin therapy for a loved one, leading to treatment delays.

Key Market Trends

Customization and Personalization

Manufacturers were offering a wider range of insulin delivery devices to accommodate individual preferences. This includes insulin pens, insulin pumps, patch pumps, and more. Patients could choose the device that aligns with their lifestyle and comfort. Insulin pumps with the ability to set variable basal rates gained popularity. Patients could personalize their insulin delivery based on their daily routines, physical activity, and other factors that affect insulin requirements. Customizable bolus dosing features allowed patients to adjust insulin doses before or after meals, depending on their specific dietary habits and glucose levels. Many insulin delivery devices were equipped with connectivity features, enabling patients to sync their devices with smartphone apps. This allowed for real-time data tracking and personalization of insulin dosing. The ability to remotely monitor and adjust insulin delivery settings was a trend, particularly for patients who required caregiver support or healthcare professional oversight. Some insulin delivery devices incorporated smart algorithms that could predict and prevent hypoglycemia or hyperglycemia, offering a personalized approach to glycemic control. Manufacturers focused on creating user-friendly interfaces, making it easier for patients to customize and personalize their device settings.

Segmental Insights

Product Type Insights

In 2024, the India Insulin Delivery Devices Market largest share was held by Pen Needles segment and is predicted to continue expanding over the coming years. Pen needles are user-friendly and relatively simple to use, making them a preferred choice for many diabetes patients. They offer a convenient and discreet way to administer insulin, especially for those who self-administer their insulin injections. Pen needles are designed to minimize pain during injection, which enhances patient comfort and adherence to treatment regimens. Reduced pain can lead to a better patient experience. Pen needles offer precise dose measurement, which is crucial for people with diabetes who need to administer accurate insulin doses. This accuracy contributes to effective blood sugar control. Pen needles come in a variety of lengths and gauges, allowing patients to choose the one that suits their preferences and needs. This adaptability enhances patient satisfaction. Most pen needles are disposable, eliminating the need for needle changes and reducing the risk of infection. This feature aligns with healthcare safety standards. Pen needles are readily available in retail pharmacies and healthcare settings across India, making them easily accessible to patients. Their widespread availability contributes to their market dominance.

Distribution Channel Insights

In 2024, the India Insulin Delivery Devices Market largest share was held by Retail Pharmacies segment and is predicted to continue expanding over the coming years.  Retail pharmacies are widely distributed across urban and rural areas in India, making insulin and insulin delivery devices easily accessible to a broad population. Patients can purchase these products without having to visit specialized healthcare facilities. Retail pharmacies often have an extensive distribution network, which allows them to reach even remote areas. This network enables the efficient delivery of insulin and insulin delivery devices to many patients. Many insulin products, such as insulin pens and some insulin syringes, are available over the counter in India, which means patients can purchase them directly from retail pharmacies without a prescription. Retail pharmacies provide convenience to patients who may prefer to pick up their insulin and related devices while purchasing other healthcare or household products. Patients can also consult pharmacists for guidance on proper insulin administration. Pharmacists in retail pharmacies can offer basic education and information to patients about insulin therapy, insulin delivery devices, and proper storage, promoting better adherence to treatment plans. 

Download Free Sample Report

Regional Insights

The North India region dominates the India Insulin Delivery Devices Market in 2024. North India is one of the most densely populated regions in the country. With a higher population, there is a larger pool of potential diabetes patients, creating a significant demand for insulin and insulin delivery devices. North India includes major urban centers such as Delhi, NCR (National Capital Region), and several other rapidly urbanizing cities. Urbanization often leads to lifestyle changes, including dietary habits, which can contribute to a higher prevalence of diabetes. Urban areas also tend to have better access to healthcare services, including diabetes management. The North Indian region is home to some of India's most advanced and well-equipped healthcare facilities, including hospitals, clinics, and specialized diabetes care centers. These institutions are more likely to offer a wide range of insulin delivery devices. North India has a higher concentration of healthcare professionals, including endocrinologists and diabetes educators. This can lead to better diabetes care, including the prescription and use of insulin delivery devices.

Recent Developments

  • In March 2024, Researchers have developed a cutting-edge pancreas-mimicking system for delivering insulin in diabetes treatment. This novel silk-based hydrogel system, which replicates the function of the pancreas, represents a significant advancement in insulin delivery for diabetes care. The innovative approach offers a more effective and responsive method for insulin release, presenting a promising solution to the challenges encountered by individuals with Type 1 and advanced stage Type 2 diabetes.

Key Market Players

  • Biocon Limited
  • India Medtronic Pvt. Ltd.
  • Roche Products (India) Pvt. Ltd.
  • Becton Dickinson India Private Limited
  • Novo Nordisk India Pvt Ltd
  • Sanofi Healthcare India Pvt. Ltd.
  • Eli Lilly & Co (India) Pvt. Ltd
  • Abbott India Ltd
  • B. Braun Medical SE


By Product Type

By Distribution Channel

By End-User

By Region

  • Pens
  • Pumps
  • Pen Needles
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

·         Hospitals & Clinics

·         Homecare

·         Others

·         North India

·         South India

·         East India

·         West India

Report Scope:

In this report, the India Insulin Delivery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • India Insulin Delivery Devices Market, By Product Type:

o   Pens

o   Pumps

o   Pen Needles

o   Others

  • India Insulin Delivery Devices Market, By Distribution Channel:

o   Hospital Pharmacies

o   Retail Pharmacies

o   Online Pharmacies

o   Others

  • India Insulin Delivery Devices Market, By End-User:

o   Hospitals & Clinics

o   Homecare

o   Others

  • India Insulin Delivery Devices Market, By region:

o   North India

o   South India

o   East India

o   West India


Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Insulin Delivery Devices Market.

Available Customizations:

India Insulin Delivery Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India Insulin Delivery Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    India Insulin Delivery Devices Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value & Volume

5.2.  Market Share & Forecast

5.2.1.        By Product Type (Pens, Pumps, Pen Needles, Others)

5.2.2.        By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)

5.2.3.        By End User (Hospitals & Clinics, Homecare, Others)

5.2.4.    By Region (North India, South India, East India, West India)

5.2.5.    By Company

5.3.  Product Market Map 

6.    North India Insulin Delivery Pens Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Product Type

6.2.2.    By Distribution Channel

6.2.3.    By End User

7.    South India Insulin Delivery Pumps Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.        By Product Type 

7.2.2.        By Distribution Channel

7.2.3.        By End User

8.    East India Insulin Delivery Pen Needles Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.        By Product Type 

8.2.2.        By Distribution Channel

8.2.3.        By End User

9.    West India Insulin Delivery Pen Needles Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.        By Product Type

9.2.2.        By Distribution Channel

9.2.3.        By End User

10.    Market Dynamics

10.1.  Drivers

10.2.  Challenges

11. Market Trends & Developments

11.1.             Merger & Acquisition

11.2.             Product Development

11.3.             Recent Developments

12. Policy & Regulatory Landscape

13. Porters Five Forces Analysis

13.1.             Competition in the Industry

13.2.             Potential of New Entrants

13.3.             Power of Suppliers

13.4.             Power of Customers

13.5.             Threat of Substitute Products

14. India Economic Profile

15. Pricing Analysis

16. Competitive Landscape

16.1.  Biocon Limited

16.1.1.         Business Overview

16.1.2.         Product & Service Offerings

16.1.3.         Recent Developments

16.1.4.         Key Personnel

16.1.5.         SWOT Analysis

16.2.  India Medtronic Pvt. Ltd.

16.3.  Roche Products (India) Pvt. Ltd.

16.4.  Becton Dickinson India Private Limited

16.5.  Novo Nordisk India Pvt Ltd

16.6.  Sanofi Healthcare India Pvt. Ltd.

16.7.  Eli Lilly & Co (India) Pvt. Ltd

16.8.  Abbott India Ltd

16.9. B. Braun Medical SE

17. Strategic Recommendations

18. About Us & Disclaimer

Figures and Tables

Frequently asked questions


India Insulin Delivery Devices Market was valued at USD1.06 billion in 2024.


Biocon Limited, India Medtronic Pvt. Ltd., Roche Products (India) Pvt. Ltd., Becton Dickinson India Private Limited, Novo Nordisk India Pvt Ltd are some of the key players operating in the India Insulin Delivery Devices Market.


Cultural belief & Stigmas and Counterfeit Products are the challenges faced by the India Insulin Delivery Devices Market in the upcoming years.


Shifting Patient Preference for Insulin Delivery Devices and Technological advancement are the major drivers which drives the growth of India Insulin Devices Market.


Sakshi Bajaal

Business Consultant
Press Release

India Insulin Delivery Devices Market to grow with a CAGR of 7.90% through 2030

Apr, 2024

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the India Insulin Delivery Devices Market during the forecast period 2026-2030